Genomic selection for disease resilience using measures of antibody (Ab) response

Disease is a major contributor to increased costs in the swine industry. For example, the cost estimated from the Porcine Reproductive and Respiratory Syndrome (PRRS) disease alone is $664 million annually to the US swine industry (year 2012 estimate), with 45% of this cost attributable to the breeding herd and 55% attributable to the grower/finisher herd (; Boehringer Ingelheim Vetmedica GmbH).
calendar icon 17 November 2020
clock icon 2 minute read
Ellingson, J. S., Weng Y., Layton S., Ciacci-Zanella J., Roof M.B. and Faaber K.S.
(2010.) Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras.. Vaccine 28:2679–2686.
Global PRRS Solutions. Boehringer Ingelheim Vetmedica GmbH
Sanglard L.P., Fernando R.L., Gray K.A., Linhares D.C., Dekkers J.C., Niederwerder M.C. & Serão N.V.
(2020) Genetic analysis of antibody response to porcine reproductive and respiratory syndrome vaccination as an indicator trait for reproductive performance in commercial sows. Frontiers in genetics.
Serão N.V., Matika O., Kemp R.A., Harding J.C.S., Bishop S.C., Plastow G.S. & Dekkers J.C.M.
(2014) Genetic analysis of reproductive traits and antibody response in a PRRS outbreak herd,. Journal of Animal Science. 92: (2905–21).
Serão, N. V., Kemp, R. A., Mote, B. E., Willson, P., Harding, J. C., Bishop, S. C., Plastow, G. S., & Dekkers, J. C.
(2016) Genetic and genomic basis of antibody response to porcine reproductive and respiratory syndrome (PRRS) in gilts and sows.. Genetics, selection, evolution : GSE. 48(1), 51.

Chad Bierman, PhD,

Geneticist at Genesus Inc.
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.